NYSE Euronext verwelkomt Cryo-Save op haar Europese markt

Amsterdam, 22 October 2009 – Dutch-based leading European stem cell storage bank, Cryo-Save Group N.V. (NYSE Euronext: CRYO) completed its listing on NYSE Euronext Amsterdam today.

Cryo-Save has storage and processing facilities in 5 countries and is operating in 38 countries in Europe, Asia and Africa. With over 115.000 samples stored, Cryo-Save is Europe’s largest adult stem cell storage bank. Cryo-Save shares trade on NYSE Euronext under the symbol 'CRYO' and are denominated in Euros. After opening, the first market price was €6.30 per share. Based on the total number of 9,639,191 shares the total market capitalization of the company at opening price was €60,726,903.

Press Release Footer

About Euronext
Euronext is the leading European capital market infrastructure, covering the entire capital markets value chain, from listing, trading, clearing, settlement and custody, to solutions for issuers and investors. Euronext runs MTS, one of Europe’s leading electronic fixed income trading markets, and Nord Pool, the European power market. Euronext also provides clearing and settlement services through Euronext Clearing and its Euronext Securities CSDs in Denmark, Italy, Norway, and Portugal. As of March 2025, Euronext’s regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway, and Portugal host nearly 1,800 listed issuers with around €6.3 trillion in market capitalisation, a strong blue-chip franchise and the largest global centre for debt and fund listings. With a diverse domestic and international client base, Euronext handles 25% of European lit equity trading. Its products include equities, FX, ETFs, bonds, derivatives, commodities and indices.
For the latest news, follow us on X (x.com/euronext) and LinkedIn (linkedin.com/company/euronext).

_Disclaimer
_{This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.}

_{This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at}_{www.euronext.com/terms-use}_.